Wang, Jun
Shi, Wei
Khiati, Dhiaedin
Shi, Bingpei
Shi, Xiaojuan
Luo, Dandan
Wang, Yin
Deng, Rencai
Huang, Huayu
Li, Jian
Yan, Weili
Yang, Hong
Funding for this research was provided by:
Shanghai municipality to further accelerated the three-year action plan for the development of Traditional Chinese Medicine project funding (ZY (2018-2020)-ZYBZ-17)
Article History
Received: 27 July 2019
Accepted: 11 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: The central ethical approval has been confirmed from the Research Ethical Board of Children’s Hospital of Fudan University (certificate number 2019 (NO.024)), and we will not begin recruiting at other centres in the trial until local ethical approval has been obtained. In the case of any changes to the study protocol, we will submit a written application form to the Research Ethics Board. They will decide whether or not it is necessary to change the study protocol. The Research Ethics Board will supervise all procedures of the study. The purpose and risks of the trial will be explained in detail to the participants, who will be required to write their informed consent to indicate that they agree with the protocol and will participate in the trial. The participants will be able to quit at any time during the study period.
: Not applicable.
: The authors declare that they have no competing interests.